Clinical supply services for radiopharmaceuticals represent one of the most logistically demanding domains in pharmaceutical logistics. As a dedicated Radiopharmaceutical CRDMO and CRO, Protheragen delivers comprehensive Clinical Supply Services that integrate just-in-time manufacturing coordination, specialized cold-chain logistics, radioactive material transport compliance, and real-time supply chain orchestration to ensure that investigational and commercial radiopharmaceuticals reach clinical sites with maximum potency, minimum waste, and full regulatory adherence.
Clinical supply services in the radiopharmaceutical sector encompass the end-to-end coordination of investigational product manufacturing, packaging, distribution, and site delivery required to support clinical trials and commercial patient access. The defining characteristic of this supply chain is the simultaneous management of three critical constraints: radioactive decay, which continuously reduces product potency from the moment of synthesis; cold-chain integrity, which must be maintained throughout transit to preserve chemical stability; and regulatory compliance with Class 7 hazardous materials regulations (IAEA SSR-6, IATA DGR, ADR), which govern packaging, labeling, documentation, and carrier qualification for radioactive shipments. These constraints create a supply chain where traditional inventory models are impossible, lead times are measured in hours rather than days, and every shipment requires precise alignment between manufacturing schedules, patient appointment calendars, imaging equipment availability, and site radiopharmacy capabilities.
Fig 1. The production and distribution network of radiopharmaceuticals in China. (Hu, Ji, et al., 2022)
The radiopharmaceutical supply chain is typically structured as a multi-node network involving isotope production facilities (reactors or cyclotrons), centralized or decentralized radiopharmaceutical manufacturing sites (CDMOs or radiopharmacies), specialized logistics providers with Class 7 certification, and clinical sites with licensed nuclear medicine departments. For clinical trials, the supply chain must also accommodate dynamic patient recruitment rates, protocol amendments, and multi-site coordination across potentially global geographies. The complexity is further amplified for theranostic programs, where diagnostic and therapeutic doses must be synchronized, and for alpha-emitting radiopharmaceuticals, where shorter half-lives and higher radiation levels demand even more stringent logistics control. Effective clinical supply services require not only operational excellence in manufacturing and logistics but also deep expertise in nuclear medicine workflows, regulatory compliance, and risk mitigation strategies to handle the inevitable disruptions—weather delays, equipment failures, or patient cancellations—that can cascade through a just-in-time system.
Protheragen delivers comprehensive Clinical Supply Services specifically engineered for the radiopharmaceutical industry, integrating just-in-time manufacturing coordination, specialized cold-chain logistics, Class 7 radioactive material transport, and real-time supply chain orchestration to ensure that every investigational and commercial radiopharmaceutical dose reaches its destination with optimal potency, full regulatory compliance, and minimal waste. Our integrated CRDMO and CRO platform connects isotope procurement, GMP manufacturing, validated packaging, certified transport, and site delivery into a seamless, traceable network that supports clinical trials and commercial operations across diverse geographies and therapeutic modalities.
We offer full logistics coordination for investigator-initiated radiopharmaceutical trials matching academic timelines and limited patient recruitment. Covering GMP batch delivery with just-in-time schedules to reduce radionuclide decay, we assess site radiopharmacy conditions, train operators, track shipments in real time and arrange radioactive waste recycling under radiation safety rules.
We supply custom radiolabeled probes, cold precursors and research radionuclides for preclinical in vitro & in vivo research labs. Each shipment comes with COA, stability records and custody documents. We adopt certified low-activity packaging complying with IATA Class 7 rules and stable cold chain for temperature-sensitive materials.
We handle distribution of diagnostic and therapeutic radiopharmaceuticals for Phase I–III multi-center trials. We align GMP production with patient enrollment forecasts, allocate inventory dynamically and support theranostic core lab coordination. 24/7 tracking and emergency contingency plans guarantee accurate, on-time dosing for all trial sites worldwide.
We operate post-approval commercial radiopharmaceutical distribution to medical facilities. We complete clinical-to-commercial supply transition via scaled manufacturing and regional distribution hubs, conduct demand forecasting and inventory control, and handle product recall, returns and post-market stability monitoring complying with GMP, GDP and pharmacovigilance rules.
We supply validated Type A shielding packages with cold insulation compliant with IATA Class 7 DGR and GDP. Our team calculates transport indexes, completes shipping declarations and selects proper radioactive labels. Real-time temperature & radiation monitoring, full custody logs and incident emergency protocols ensure safe, compliant delivery of all radioactive materials.
Protheragen's Clinical Supply Services follow a structured, phase-gated workflow designed to ensure that every radiopharmaceutical dose is manufactured, packaged, distributed, and delivered with maximum potency, regulatory compliance, and operational efficiency. Our integrated approach coordinates manufacturing, logistics, and clinical operations to minimize waste, prevent delays, and ensure seamless patient access.
Whether you are launching a first-in-human IIT, scaling a multi-site Phase III theranostic trial, or transitioning a radiopharmaceutical from clinical development to commercial distribution, Protheragen is ready to support your program with the logistics expertise, regulatory compliance, and supply chain infrastructure it demands. Reach out to us today to discuss how our Clinical Supply Services can ensure that every patient receives the right dose at the right time, every time. Contact our supply chain strategy team to schedule a consultation and explore a tailored partnership approach.
Reference